Verona Pharma plc (VRNA)
NASDAQ: VRNA · IEX Real-Time Price · USD
15.47
+0.16 (1.05%)
At close: Apr 26, 2024, 4:00 PM
15.74
+0.27 (1.75%)
After-hours: Apr 26, 2024, 4:11 PM EDT
Verona Pharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
79
Market Cap
1.20B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 458.00K | -39.54M | -98.86% |
Dec 31, 2021 | 40.00M | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Omnicell | 1.15B |
Pacira BioSciences | 674.98M |
Phreesia | 356.30M |
Kiniksa Pharmaceuticals | 270.26M |
Xencor | 168.34M |
Deciphera Pharmaceuticals | 163.36M |
4D Molecular Therapeutics | 20.72M |
Tarsus Pharmaceuticals | 17.45M |
VRNA News
- 2 days ago - Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 7 weeks ago - Andrew Fisher Joins Verona Pharma as General Counsel - GlobeNewsWire
- 2 months ago - Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update - GlobeNewsWire
- 3 months ago - Michael Austwick Joins Verona Pharma as Non-Executive Director - GlobeNewsWire
- 4 months ago - Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital - GlobeNewsWire
- 5 months ago - Verona Pharma's President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award - GlobeNewsWire